Iphigenia Leonidou Koumenis

Iphigenia (Effie) Leonidou Koumenis is an accomplished clinical operations expert with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as a Strategic Clinical Operations Advisor at Sana Biotechnology, Inc. and as the owner of Lyphira Ltd, Iphigenia specializes in consulting for clinical operations in cell therapy, antibodies, and small molecules. Previous roles include Executive Director at Century Therapeutics, Inc., where Iphigenia led clinical operations for cell therapy products, and Clinical Operations Consultant for Aquamare LLC. Additional positions include Head of Clinical Operations at Imvax, Inc., Senior Vice President of Clinical Operations at Orsenix, and various leadership roles at Novartis, Novo Nordisk, Incyte, and Targacept, Inc. Iphigenia holds a Master's degree in Bioanalytical Chemistry from the University of Houston and a Bachelor's degree in Chemistry from the University of Thessaloniki, along with a certificate in Marketing from The Wharton School.